Investing Profile

John de Koning

VCInvestor
Partner at EQT Life Sciences
eqtgroup.com/about/people/joh...Amsterdam, Netherlands
Photo of John de Koning, Partner at EQT Life Sciences
cb
$11.0M - $65.0M
$25.0M
11
€260M
CompanyStageDateRound SizeTotal Raised
ATB Therapeutics
Series ANov 2024$57M
$57M
Co-investors: Vincent Brichard
Tubulis
Series BMar 2024$140M
$210M
Co-investors: Sofia Ioannidou (Andera Partners), Sebastian Pünzeler (Coparion)
VarmX
Series BMay 2023$37M
Series BJul 2020$36M
$83M
Co-investors: Hermann Hauser (Amadeus Capital Partners), Roel Bulthuis (INKEF Capital), Oscar Slotboom (BGV (BioGeneration Ventures))
etherna immunotherapies
Series BAug 2022$39M
Series AMar 2016$27M
$66M
Visus Therapeutics
Debt FinancingAug 2021$20M
$61M
Co-investors: Tony Nguyen (RTW Investments), Martin Alexander Gershon (Endeavor Venture Funds)
Onward
Series UnknownApr 2021$32M
$51M
Co-investors: Leo Polovets (Susa Ventures), Caitlin Strandberg (Lerer Hippeau), Edward Lando (Pareto Holdings), Mark A. Johnson (TTV Capital), Luis Valdich (Citi Ventures), Natty Zola (Matchstick Ventures), Ryan Broshar (Matchstick Ventures), Dalton Caldwell (Y Combinator), Mark Joseph (Early Light Ventures), Jett McCandless
Merus
Series CApr 2015$79M
Series BOct 2013$42M
Series BJan 2010$30M
$150M
Co-investors: Jack Nielsen (Vivo Capital), Florent Gros (Earlybird Venture Capital), Lionel Carnot (Earlybird Venture Capital)